AAAAAA

   
Results: 1-8 |
Results: 8
The in vivo effects of beta-3-receptor agonist CGP-12177 on thyroxine deiodination in cold-exposed, sympathectomized rat brown fat
Authors: Hofer, D Raices, M Schauenstein, K Porta, S Korsatko, W Hagmuller, K Zaninovich, A
Citation: D. Hofer et al., The in vivo effects of beta-3-receptor agonist CGP-12177 on thyroxine deiodination in cold-exposed, sympathectomized rat brown fat, EUR J ENDOC, 143(2), 2000, pp. 273-277
Non-solvent shock agglomeration as a novel method for preparing Ibuprofen - Part .6 - Stability investigations of S(+)-ibuprofen
Authors: Moller, T Korsatko, W
Citation: T. Moller et W. Korsatko, Non-solvent shock agglomeration as a novel method for preparing Ibuprofen - Part .6 - Stability investigations of S(+)-ibuprofen, PHARMAZIE, 55(6), 2000, pp. 449-453
Non-solvent shock agglomerated ibuprofen: production and evaluation of retarded formulations
Authors: Moller, T Korsatko, W
Citation: T. Moller et W. Korsatko, Non-solvent shock agglomerated ibuprofen: production and evaluation of retarded formulations, PHARMAZIE, 55(2), 2000, pp. 114-119
Non-solvent shock agglomerated ibuprofen: Production and evaluation of quick release dosage forms
Authors: Moller, T Korsatko, W
Citation: T. Moller et W. Korsatko, Non-solvent shock agglomerated ibuprofen: Production and evaluation of quick release dosage forms, PHARMAZIE, 55(1), 2000, pp. 53-58
The "non-solvent shock agglomeration"-technology as a novel alternative method for the production of ibuprofen, part 1
Authors: Moller, T Korsatko, W
Citation: T. Moller et W. Korsatko, The "non-solvent shock agglomeration"-technology as a novel alternative method for the production of ibuprofen, part 1, PHARMAZIE, 54(7), 1999, pp. 524-530
Preparation techniques for racemic and optically pure ibuprofen, evaluation of resulting active substance qualities
Authors: Moller, T Korsatko, W
Citation: T. Moller et W. Korsatko, Preparation techniques for racemic and optically pure ibuprofen, evaluation of resulting active substance qualities, PHARMAZIE, 54(4), 1999, pp. 280-288
The "modified non-solvent shock agglomeration"-technique, part 3
Authors: Moller, T Korsatko, W
Citation: T. Moller et W. Korsatko, The "modified non-solvent shock agglomeration"-technique, part 3, PHARMAZIE, 54(11), 1999, pp. 840-846
Non-solvent shock agglomeration technology, part 2: Influence of the preparation method on the pharmaceutic-technological properties of ibuprofen
Authors: Moller, T Korsatko, W
Citation: T. Moller et W. Korsatko, Non-solvent shock agglomeration technology, part 2: Influence of the preparation method on the pharmaceutic-technological properties of ibuprofen, PHARMAZIE, 54(10), 1999, pp. 759-765
Risultati: 1-8 |